Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Steatotic Liver Disease: Metabolic Dysfunction, Alcohol, or Both?
Katharina Staufer, Rudolf Stauber
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2108-2108
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Lubiprostone Reduces Fat Content on MRI‐PDFF in Patients With MASLD: A 48‐Week Randomised Controlled Trial
Mohamed El‐Kassas, Hala Mostafa, Wessam Abdellatif, et al.
Alimentary Pharmacology & Therapeutics (2025)
Open Access | Times Cited: 2
Metabolic and alcohol-associated liver disease (MetALD): a representation of duality
Hector Leal-Lassalle, Olga Estévez-Vázquez, Francisco Javier Cubero, et al.
npj gut and liver. (2025) Vol. 2, Iss. 1
Open Access | Times Cited: 1
Management of Metabolic-Associated Fatty Liver Disease/Metabolic Dysfunction-Associated Steatotic Liver Disease: From Medication Therapy to Nutritional Interventions
M H Miran Beygi, Salma Ahi, Samaneh Zolghadri, et al.
Nutrients (2024) Vol. 16, Iss. 14, pp. 2220-2220
Open Access | Times Cited: 13
Gender-Specific Bile Acid Profiles in Non-Alcoholic Fatty Liver Disease
Julia Fitzinger, Giovanny Rodriguez Blanco, Markus Herrmann, et al.
Nutrients (2024) Vol. 16, Iss. 2, pp. 250-250
Open Access | Times Cited: 12
The Relationship between Pathogenesis and Possible Treatments for the MASLD-Cirrhosis Spectrum
Paulina Vidal‐Cevallos, Adriana P. Sorroza-Martínez, Norberto C. Chávez‐Tapia, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4397-4397
Open Access | Times Cited: 8
Liver cancer risk across metabolic dysfunction-associated steatotic liver disease and/or alcohol: a nationwide study
Byungyoon Yun, Heejoo Park, Sang Hoon Ahn, et al.
The American Journal of Gastroenterology (2024)
Closed Access | Times Cited: 8
Assessment of ChatGPT-generated medical Arabic responses for patients with metabolic dysfunction–associated steatotic liver disease
Saleh A. Alqahtani, Reem AlAhmed, Waleed S. AlOmaim, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0317929-e0317929
Open Access | Times Cited: 1
Increased visceral fat area to skeletal muscle mass ratio is positively associated with the risk of metabolic dysfunction-associated steatotic liver disease in a Chinese population
Chenbing Liu, Nan Li, Di Sheng, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Machine Learning-Based Assessment of Survival and Risk Factors in Non-Alcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma for Optimized Patient Management
Miguel Suárez, Sergio Gil-Rojas, Pablo Martínez-Blanco, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1114-1114
Open Access | Times Cited: 6
Deciphering metabolic dysfunction‐associated steatotic liver disease: insights from predictive modeling and clustering analysis
Kazuma Mori, Yukinori Akiyama, Marenao Tanaka, et al.
Journal of Gastroenterology and Hepatology (2024) Vol. 39, Iss. 7, pp. 1382-1393
Open Access | Times Cited: 6
The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review
Teodora Biciusca, Sorina Ionelia Stan, Mara Amalia Bălteanu, et al.
Diagnostics (2023) Vol. 13, Iss. 21, pp. 3316-3316
Open Access | Times Cited: 14
The gut-liver axis in fatty liver disease: role played by natural products
Ming Zhu, Xie Ruishi, Xu Linyi, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Liver fibrosis stage classification in stacked microvascular images based on deep learning
Daisuke Miura, Hiromi Suenaga, Rino Hiwatashi, et al.
BMC Medical Imaging (2025) Vol. 25, Iss. 1
Open Access
Metabolic dysfunction‐associated steatotic liver disease and cancer risk: A cohort study
Peng Yu, Peng Wang, Fubin Liu, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
From Dysbiosis to Hepatic Inflammation: A Narrative Review on the Diet-Microbiota-Liver Axis in Steatotic Liver Disease
Andrea Pasta, Elena Formisano, Francesco Calabrese, et al.
Microorganisms (2025) Vol. 13, Iss. 2, pp. 241-241
Open Access
Liver and Atherosclerotic Risk of Alcohol Consumption in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
Shaowen Wang, C. H. Wang, Yu‐Ming Cheng, et al.
Atherosclerosis (2025) Vol. 403, pp. 119161-119161
Closed Access
Carotenoids Improve Obesity and Fatty Liver Disease via Gut Microbiota: A Narrative Review
Dorna Hashemi, Mohammad Vahedi Fard, Kimia Mohammadhasani, et al.
Food Science & Nutrition (2025) Vol. 13, Iss. 3
Open Access
System failure: Systemic inflammation following spinal cord injury
Damon J. DiSabato, Christina M. Marion, Katherine A. Mifflin, et al.
European Journal of Immunology (2023) Vol. 54, Iss. 1
Open Access | Times Cited: 10
MASLD is related to impaired alcohol dehydrogenase (ADH) activity and elevated blood ethanol levels: Role of TNFα and JNK
Katharina Bürger, Finn Jung, Katharina Staufer, et al.
Redox Biology (2024) Vol. 71, pp. 103121-103121
Open Access | Times Cited: 3
Metabolic dysfunction-associated steatotic liver disease: A pathophysiology and clinical framework to face the present and the future
Salvatore Corrao, Luigi Calvo, Walter Granà, et al.
Nutrition Metabolism and Cardiovascular Diseases (2024) Vol. 35, Iss. 2, pp. 103702-103702
Closed Access | Times Cited: 3
Metabolic dysfunction‐associated steatotic liver disease (SLD) and alcohol‐associated liver disease, but not SLD without metabolic dysfunction, are independently associated with new onset of chronic kidney disease during a 10‐year follow‐up period
Kazuma Mori, Marenao Tanaka, Tatsuya Sato, et al.
Hepatology Research (2024)
Open Access | Times Cited: 3
Clinical features and mortality outcomes of patients with MASLD only compared to those with MAFLD and MASLD
Ming-Qian Jiang, Ziyan Pan, Jacob George, et al.
Hepatology International (2024) Vol. 18, Iss. 6, pp. 1731-1739
Closed Access | Times Cited: 3
Evaluation of MRI proton density fat fraction in hepatic steatosis: a systematic review and meta-analysis
Narges Azizi, Hamed Naghibi, Madjid Shakiba, et al.
European Radiology (2024)
Closed Access | Times Cited: 3
Liver stiffness as a dynamic predictor of decompensation and mortality in alcohol-related liver disease
Majeed M. A. Ali
Deleted Journal (2024) Vol. 1, Iss. 1
Open Access | Times Cited: 3
Extent to which weight loss contributes to improving metabolic dysfunction-associated and metabolic and alcohol related/associated steatotic liver disease: a study on Japanese participants undergoing health checkups
Tatsuya Fukuda, Takahiro Okamoto, Takahiro Fukaishi, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top